ATC CODE
- N03AX11
INDICATIONS AND NEMLC RECOMMENDATIONS
INDICATION AND NEMLC RECOMMENDATION 1
INDICATION
- Initial therapy (epilepsy).
NEMLC RECOMMENDATION
- Not Approved.
REVIEW INDICATORS
- New evidence, re: clinical efficacy of topiramate vs. alternatives as add-on therapy for resistant epilepsy.
- New evidence, re: efficacy in comparison with alternatives as initial therapy for epilepsy, where the current evidence supports using the alternative agents.
DATE RATIFIED
- 3 December 2009
INDICATION AND NEMLC RECOMMENDATION 2
INDICATION
- Add-on therapy for resistant epilepsy.
NEMLC RECOMMENDATION
- Approved.
REVIEW INDICATORS
- Evidence that the product is accounting for disproportionate amount of anti-epileptic spend.
DATE RATIFIED
- 26 March 2015